3858 results for «2296»
3858 results
CTO within a bifurcation
16 May 2024 – From EuroPCR 2024
This session will present various cases of chronic total occlusions (CTOs) within a bifurcation. Participants will learn about the challenges, diagnostic techniques, and treatment strategies for these complex cases, including the use of IVUS, CT angiography, and the hybrid algorithm for successful CTO interventions.
Multivessel disease PCI guided by physiology and IVUS - LIVE case
16 May 2024 – From EuroPCR 2024
A 78-year-old woman with hypertension, dyslipidemia, and obesity, presented with angina CCS2 and preserved LV function. The coronary angiogram showed stenosis in the RCA (proximal and mid), CX, and calcified proximal and mid LAD involving D1 and D2.
The operators performed PCI on the RCA (1 stent)...
ANOCA/INOCA: when angiography is not enough to reach a diagnosis
16 May 2024 – From EuroPCR 2024
This session provides practical knowledge on the diagnosis and management of patients with ANOCA/INOCA (Angina with Non-Obstructive Coronary Arteries/Ischemia with Non-Obstructive Coronary Arteries). It covers the evaluation of microvascular and vasomotor disorders in patients with non-obstructive coronary arteries, and the causes and management of patients with...
CTO PCI: from planning to execution
16 May 2024 – From EuroPCR 2024
This session, with the collaboration of the Cyprus Society of Cardiology / Cyprus Interventional Cardiology Working Group, Tunisian Group for Interventional Cardiology and Bulgarian Society of Interventional Cardiology, covers planning and execution of CTO PCI procedures. It includes case discussions on treatment dilemmas, overcoming frequently encountered...
Comparative insights into QFR, FFR, and angiography
16 May 2024 – From EuroPCR 2024
This session, comprising selected EuroPCR 2024 Abstract submissions, focuses on various aspects of assessing and managing multivessel coronary artery disease. It includes presentations and discussions on the use of quantitative flow ratio (QFR) for assessing non-culprit lesions in acute myocardial infarction, functional assessment of surgical revascularization,...
TAVI: managing acute procedural complications
16 May 2024 – From EuroPCR 2024
From deep implantation challenges to embolization and iatrogenic dissections, each presentation highlights techniques for addressing critical procedural hurdles. Topics include bailout strategies, managing embolized valves, complex second valve placements, and handling unusual TAVR scenarios, offering insights on navigating complications and ensuring procedural safety.
Valvular and structural interventions
16 May 2024 – From EuroPCR 2024
This session features presentations and discussions on various novel transcatheter technologies for valvular and structural heart interventions. It includes a novel transcatheter tricuspid repair technology, a new endovascular aortic root and total arch stent-graft replacement system, a novel self-expandable transcatheter aortic valve, and a transcatheter mitral...
Tackling challenging scenarios of left main PCI
16 May 2024 – From EuroPCR 2024
This session, with the collaboration of the South African Society of Cardiovascular Intervention (SASCI), Bangladesh Society of Cardiovascular Intervention and Indonesian Society of Interventional Cardiology, focuses on overcoming the most challenging issues in complex left main bifurcation stenosis PCI. It includes case discussions on techniques to...
Innovations in transcatheter valve interventions: moving the flow in the right direction
13 May 2024 – From EuroPCR 2024
Feedback from Innovator's Exchange Hub
13 May 2024 – From EuroPCR 2024
Innovations in renal denervation: deja vu or reality?
13 May 2024 – From EuroPCR 2024
Feedback from Innovator's Exchange Hub
13 May 2024 – From EuroPCR 2024
Elevating quality of heart valve treatment through innovation: SAPIEN 3 Ultra RESILIA and EVOQUE valve systems
14 May 2024 – From EuroPCR 2024
Watch this session to explore how the SAPIEN 3 Ultra RESILIA valve can enhance lifetime management for patients, to find out more about the new treatment options available with the EVOQUE valve, identifying the patient populations that stand to benefit the most, and, additionally, to get...
TAVI in TAVI - LIVE case
14 May 2024 – From EuroPCR 2024
A 74-year-old male with a history of cancer, TAVI with Evolut R 34 in 2019, COPD, obesity, and RBBB presents with a symptomatic degenerated valve (regurgitation).
It was decided to implant a Sapien 3 Ultra 26, without pre-dilatation and post-dilatation, using a temporary pacing lead (due to...
Go beyond metal: exploring drug-eluting balloon technology in de-novo coronary lesions
15 May 2024 – From EuroPCR 2024
Through the study of two cases, this session examines the need for stenting bifurcation lesions and the role of DEB technology in avoiding stent-related complications in long diffuse disease. It emphasizes the benefits of SELUTION SLR balloons for de novo lesions, discussing how sustained limus release...
Identification and treatment of (sub)clinical transcatheter valve thrombosis
16 May 2024 – From EuroPCR 2024
This session offers a practical guide to CT diagnosis of HALT/RLM, highlighting the importance of taking HALT/RLM seriously and providing insights into approaching HALT/HAM and the potential impact of pharmacotherapy. Gain knowledge on determining leaflet thickening and mobility through MSCT, receive updates on antithrombotic treatment strategies...
Tough calls during complex PCI
14 May 2024 – From EuroPCR 2024
This joint session with India Live focuses on understanding the reasons for potential failures during complex PCI and strategies to overcome them. It features case presentations and discussions on successfully managing challenging scenarios, including cases where the operator had previously failed, as well as cases where...
Align for the future with case-based discussions on next generation balloon expandable transcatheter heart valve technology
16 May 2024 – From EuroPCR 2024
Join this EuroPCR 2024 session to delve into the cutting-edge innovations and techniques shaping transcatheter heart valve interventions. Witness firsthand the versatility of the Myval Octacor THV platform, navigating through challenging scenarios with ease, explore the significance of lifetime patient management in TAVI, unveiling the novel...
Late-breaking trials: TAVI head-to-head
14 May 2024 – From EuroPCR 2024
This session presents the latest findings from several late-breaking trials comparing different transcatheter aortic valve implantation (TAVI) approaches. Topics include outcomes in women with small aortic annuli, the comparison of percutaneous versus surgical treatment for patients with aortic stenosis and coronary disease, the impact of valve...
Challenges in the treatment of STEMI: unexpected findings and smart solutions
15 May 2024 – From EuroPCR 2024
